Canlyniadau Chwilio - Daniel Cejka

  • Dangos 1 - 11 canlyniadau o 11
Mireinio'r Canlyniadau
  1. 1
    Renal Elimination of Sclerostin Increases With Declining Kidney Function

    Renal Elimination of Sclerostin Increases With Declining Kidney Function gan Daniel Cejka, Rodrig Marculescu, Nicolas Kozakowski, Max Plischke, Thomas Reiter, Alois Gessl, Martin Haas

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Everolimus (RAD001) and anti-angiogenic cyclophosphamide show long-term control of gastric cancer growth in vivo

    Everolimus (RAD001) and anti-angiogenic cyclophosphamide show long-term control of gastric cancer growth in vivo gan Daniel Cejka, Matthias Preusser, Adelheid Wöehrer, Wolfgang Sieghart, Sabine Strommer, Johannes Werzowa, Thorsten Fuereder, Volker Wacheck

    Cyhoeddwyd 2008
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Klotho: a potential therapeutic target in aging and neurodegeneration beyond chronic kidney disease—a comprehensive review from the ERA CKD-MBD working group

    Klotho: a potential therapeutic target in aging and neurodegeneration beyond chronic kidney disease—a comprehensive review from the ERA CKD-MBD working group gan Mehmet Kanbay, Mazlum Çöpür, Laşin Özbek, Ali Mutlu, Daniel Cejka, Paola Ciceri, Mario Cozzolino, Mathias Haarhaus

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Dual inhibition of EGFR and mTOR pathways in small cell lung cancer

    Dual inhibition of EGFR and mTOR pathways in small cell lung cancer gan Katharina Schmid, Zsuzsanna Bagó-Horváth, Walter Berger, Andrea Haitel, Daniel Cejka, Johannes Werzowa, Martin Filipits, Beata Herberger, Hubert Hayden, Wolfgang Sieghart

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Sclerostin and Dickkopf-1 in Renal Osteodystrophy

    Sclerostin and Dickkopf-1 in Renal Osteodystrophy gan Daniel Cejka, Johann Herberth, Adam J. Branscum, David W. Fardo, Marie‐Claude Monier‐Faugere, Danielle Diarra, Martin Haas, Hartmut H. Malluche

    Cyhoeddwyd 2010
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Bone Microarchitecture in Hemodialysis Patients Assessed by HR-pQCT

    Bone Microarchitecture in Hemodialysis Patients Assessed by HR-pQCT gan Daniel Cejka, Janina Patsch, Michael Weber, Danielle Diarra, Markus Riegersperger, Željko Kikić, Christian Krestan, Claudia Schueller-Weidekamm, F. Kainberger, Martin Haas

    Cyhoeddwyd 2011
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Mammalian Target of Rapamycin Pathway Activity in Hepatocellular Carcinomas of Patients Undergoing Liver Transplantation

    Mammalian Target of Rapamycin Pathway Activity in Hepatocellular Carcinomas of Patients Undergoing Liver Transplantation gan Wolfgang Sieghart, Thorsten Fuereder, Katharina Schmid, Daniel Cejka, Johannes Werzowa, Fritz Wrba, Xiaowei Wang, Diego Gruber, Susanne Rasoul‐Rockenschaub, Markus Peck‐Radosavljevic, Volker Wacheck

    Cyhoeddwyd 2007
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients

    Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients gan Daniel Cejka, A. Jäger-Lansky, Heidi Kieweg, Michael Weber, Christian Bieglmayer, Dominik G. Haider, Danielle Diarra, Janina Patsch, Franz Kainberger, Barbara Bohle, Martin Haas

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Mcl-1 overexpression in hepatocellular carcinoma: A potential target for antisense therapy

    Mcl-1 overexpression in hepatocellular carcinoma: A potential target for antisense therapy gan Wolfgang Sieghart, Doris Losert, Sabine Strommer, Daniel Cejka, Katharina Schmid, Susanne Rasoul‐Rockenschaub, Martin Bodingbauer, Richard Crevenna, Brett P. Monia, Markus Peck‐Radosavljevic, Volker Wacheck

    Cyhoeddwyd 2005
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Management of fracture risk in CKD—traditional and novel approaches

    Management of fracture risk in CKD—traditional and novel approaches gan Mathias Haarhaus, Louise Aaltonen, Daniel Cejka, Mario Cozzolino, Renate T de Jong, Patrick C. D’Haese, Pieter Evenepoel, Marie‐Hélène Lafage‐Proust, Sandro Mazzaferro, Eugene McCloskey, Syazrah Salam, Hanne Skou Jørgensen, Marc Vervloet

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Osteoporose – Definition, Risikoerfassung, Diagnose, Prävention und Therapie (Update 2024)

    Osteoporose – Definition, Risikoerfassung, Diagnose, Prävention und Therapie (Update 2024) gan Hans Peter Dimai, Christian Muschitz, Karin Amrein, Rosemarie Bauer, Daniel Cejka, R. Gasser, Reinhard Gruber, Judith Haschka, Timothy Hasenöhrl, Franz Kainberger, Katharina Kerschan‐Schindl, Roland Kocijan, Jürgen König, Norbert Kroißenbrunner, Ulrike Kuchler, Christine Oberforcher, Johannes Ott, Georg Pfeiler, Peter Pietschmann, Paul Puchwein, Alexander Schmidt-Ilsinger, Ralf Harun Zwick, Astrid Fahrleitner‐Pammer

    Cyhoeddwyd 2024
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: